Literature DB >> 20959640

Acetylcholine receptor agonist reduces brain damage induced by hypoxia-ischemia in newborn rats.

Seishi Furukawa1, Hiroshi Sameshima, Li Yang, Tsuyomu Ikenoue.   

Abstract

OBJECTIVE: The newborn rat model has been developed to elucidate the mechanism and management of perinatal brain damage. Our study hypothesis is that an acetylcholine receptor agonist (carbachol) reduces hypoxia-ischemia (HI)-induced brain damage in a well-established newborn rat model. STUDY
DESIGN: 7-day-old Wistar rats were divided into 3 groups at random: carbachol preinjection and HI (Carb/HI), saline preinjection and HI (Saline/HI), and only HI (HI). Rats were subjected to left carotid artery ligation followed by 2 hours of hypoxia (8% oxygen). We injected carbachol or saline before hypoxic loading. After 7 days, we checked for brain damage.
RESULTS: In the cerebral cortex, 25% of the Carb/HI group showed mild neural damage, and the remaining 75% showed no damage. In contrast, more than 80% of the Saline/HI and HI groups had severe neural damage. Similarly, neural damage significantly decreased in Carb/HI compared with Saline/HI and HI for CA1, CA2, CA3, and the dentate gyrus of hippocampal regions.
CONCLUSION: Acetylcholine receptor agonist has a potent effect by reducing perinatal brain damage induced by HI in newborn rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959640     DOI: 10.1177/1933719110385129

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  3 in total

1.  Tissue Injury and Astrocytic Reaction, But Not Cognitive Deficits, Are Dependent on Hypoxia Duration in Very Immature Rats Undergoing Neonatal Hypoxia-Ischemia.

Authors:  L E Durán-Carabali; E F Sanches; F K Odorcyk; F Nicola; R G Mestriner; L Reichert; D Aristimunha; A S Pagnussat; C A Netto
Journal:  Neurochem Res       Date:  2019-09-28       Impact factor: 3.996

2.  Administration of Huperzia quadrifariata Extract, a Cholinesterase Inhibitory Alkaloid Mixture, has Neuroprotective Effects in a Rat Model of Cerebral Hypoxia-Ischemia.

Authors:  F K Odorcyk; E F Sanches; F C Nicola; J Moraes; L F Pettenuzzo; J Kolling; C Siebert; A Longoni; E L Konrath; A Wyse; C A Netto
Journal:  Neurochem Res       Date:  2016-11-24       Impact factor: 3.996

3.  Hypoxic-ischemic neonatal encephalopathy: animal experiments for neuroprotective therapies.

Authors:  Hiroshi Sameshima; Tsuyomu Ikenoue
Journal:  Stroke Res Treat       Date:  2013-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.